Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives.

Cancers (Basel) · 2021 · PMC8616337 · PMID 34830815

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients with strong expression of CXCR-4 end VEGF receptor-3 showed a trend toward better OS when treated with FPL.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.